oncology pipeline
Gilead’s $5 Billion Bet Targets Tubulis’ Potential Best-in-Class ADC Platform in Oncology Push
2026-04-07
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




